Salesforce vs. UiPath: Which Technology Stock Is a Better Buy in 2026?
As software giants integrate agentic artificial intelligence, investors must decide between established titans and specialized innovators. Choosing between Salesforce (CRM +1.84%) and UiPath (PATH -1.58%) involves weighing mature profitability against high-growth automation.
Salesforce is the global leader in customer relationship management, providing a massive suite of cloud-based sales and marketing tools. UiPath focuses on robotic process automation, helping companies use software robots to handle repetitive tasks. These firms offer contrasting ways to play the ongoing shift toward digital efficiency and automated workflows.
CRM & PATH: Performance Comparison
Key Financial Metrics
CRM – Salesforce
$237.58
+1.84% (+$4.30)
PATH – UiPath
$13.04
–1.58% (–$0.21)
Market Cap
$192B
52wk Range
$146.32 – $269.11
Gross Margin
74.69%
P/E Ratio
21.26
EPS (TTM)
$10.97
Dividend & Yield
$1.74 (0.74%)
Market Cap
$6.9B
52wk Range
$9.20 – $19.84
Gross Margin
82.14%
P/E Ratio
19.71
EPS (TTM)
$0.67
Dividend & Yield
N/A
CRM – Salesforce
$237.58
+1.84% (+$4.30)
Market Cap
$192B
52wk Range
$146.32 – $269.11
Gross Margin
74.69%
P/E Ratio
21.26
EPS (TTM)
$10.97
Dividend & Yield
$1.74 (0.74%)
PATH – UiPath
$13.04
–1.58% (–$0.21)
Market Cap
$6.9B
52wk Range
$9.20 – $19.84
Gross Margin
82.14%
P/E Ratio
19.71
EPS (TTM)
$0.67
Dividend & Yield
N/A
The case for Salesforce
Salesforce builds software that brings sales, service, marketing, and data together on a single platform for enterprises. It remains a leader among tech stocks, serving a global customer base across many industries. It recently expanded its focus on agentic AI, which allows software agents to complete tasks without constant human supervision.
In FY 2026, revenue reached nearly $41.5 billion, representing a growth rate of roughly 9.6% over the previous year. This growth was accompanied by net income of close to $7.5 billion, up from $6.2 billion in the prior fiscal year. The company reported a net margin of nearly 18%, suggesting it successfully converted a significant portion of revenue into profit.
The debt-to-equity ratio, which measures total debt against shareholder equity, is nearly 0.3x. Current ratio is close to 0.8x, which evaluates the ability to cover short-term debts with current assets. Free cash flow, defined as cash from operations minus capital expenditures, was roughly $14.4 billion. Note that stock-based compensation represented roughly 23.4% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.
The case for UiPath
UiPath provides an orchestration platform that combines AI agents and robots to automate complex business processes. It targets large enterprise clients and relies on a distribution network of channel partners to reach a worldwide market. The company is notable for its high concentration of revenue from customers spending over $100,000 annually.
In FY 2026, revenue reached approximately $1.6 billion, a growth rate of nearly 12.7% compared to the prior year. This marked a major milestone as the company posted a net income of roughly $282.3 million. This performance represents a significant turnaround from the net loss recorded in fiscal year 2025, resulting in a net margin of close to 17.5%.
As of its January 2026 balance sheet, the debt-to-equity ratio was 0.0x because the company holds no debt. The current ratio is roughly 2.5x, indicating a strong ability to meet short-term obligations with liquid assets. Free cash flow reached nearly $352.2 million. Note that stock-based compensation represented roughly 78.3% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.
Risk profile comparison
Cybersecurity, data privacy laws like GDPR, and intense competition in the AI market are primary concerns for Salesforce. Execution risks related to large acquisitions and periodic disruptions to the sales organization also impact growth. The company must stay ahead as rivals like Microsoft (MSFT +0.52%) integrate generative AI features into their own platforms.
UiPath faces risk from its reliance on a limited number of top-tier customers and channel partners for sales. Rapidly evolving AI technology could disrupt demand for traditional automation if new tools are perceived as more effective. Additionally, difficulties in managing operational scaling and restructuring activities may divert management’s focus from its core growth objectives.
Valuation comparison
Salesforce features a lower Forward P/E, which compares the stock price to future earnings estimates, while UiPath has a lower P/S ratio.
| Metric | Salesforce | UiPath |
|---|---|---|
| Forward P/E | 14.2x | 17.0x |
| P/S ratio | 4.7x | 4.4x |
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy in 2026?
I’d go with Salesforce. Agentforce is opening up new enterprise workflows that go well beyond the company’s traditional CRM roots, giving the platform an exciting growth dimension that did not exist two years ago. Its combination of record operating cash flow, thousands of Agentforce paid deals closed since launch, and an AI and data cloud business that more than doubled year over year makes it one of the more compelling software platforms in the market right now.
UiPath has made genuine strides. After years of burning cash and missing expectations, it has strung together four consecutive profitable quarters, raised its outlook, and is winning enterprise customers who are using its automation platform to deploy AI across their operations.
But UiPath is growing at a more modest pace, and the stock has struggled to gain traction even when the company delivers good news, which tells you that many investors are still waiting to be convinced the turnaround is real. Salesforce is the more established, faster-growing, and more profitable platform right now. For patient investors, that combination is the stronger foundation.
